Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Title: Editorial [Hot Topic: Relaxin and Related Peptides (Guest Editors: A. Ferlin and C. Foresta)]
Volume: 5 Issue: 5
Author(s): A. Ferlin and C. Foresta
Affiliation:
Export Options
About this article
Cite this article as:
Ferlin A. and Foresta C., Editorial [Hot Topic: Relaxin and Related Peptides (Guest Editors: A. Ferlin and C. Foresta)], Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents 2005; 5 (5) . https://dx.doi.org/10.2174/156801305774322439
DOI https://dx.doi.org/10.2174/156801305774322439 |
Print ISSN 1568-0134 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0134 |
15
Related Articles
-
Hemostatic Factors and the Metabolic Syndrome
Current Vascular Pharmacology Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Establishment of Conditionally Immortalized Cell Lines with Specific Functions and its Application to Differential Gene Expression Analysis by DNA Microarray Technology
Current Pharmaceutical Analysis Patent Annotations
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?
Current Pharmaceutical Design Deciphering Transcriptional Regulation Relevant to Eating Behavior
Current Genomics Effects of Dietary Non-Fiber Carbohydrates on Composition and Function of Gut Microbiome in Monogastrics: A Review
Protein & Peptide Letters Subject Index To Volume 1
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs
Current Pharmaceutical Design (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews Mitochondria in Cancer Stem Cells: A Target for Therapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Regulation of Neuroimmune-Endocrine Interactions: Mechanisms,Molecular Pathways Unraveled and the Pivotal Role of Cytokines – A Unsung Putative Bidirectional Interdependence between the Immune and Neuroendocrine Interfaces
Current Immunology Reviews (Discontinued) WNT4 Signaling in Female Gonadal Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Male Contraception: An Overview of the Potential Target Events
Endocrine, Metabolic & Immune Disorders - Drug Targets Neuroprotective Effects of <i>Nardostachys jatamansi</i> Against BSO Induced Anxiety via its Antioxidant Machinery and by Elevating Catecholamines and GABA levels in Mice
Current Traditional Medicine Application of Machine Learning Approaches for Protein-protein Interactions Prediction
Medicinal Chemistry From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry